Protalix BioTherapeutics, Inc. (PLX)

NYSEAMERICAN: PLX · Real-Time Price · USD

2.410

+0.030 (1.26%)

At close: Aug 24, 2026, 4:00 PM EDT

2.410

0.00 (0.00%)

After-hours: Aug 24, 2026, 8:00 PM EDT

Protalix BioTherapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	80.62	52.74	53.4	65.49	47.64	38.35
Revenue Growth	30.14%	-1.23%	-18.47%	37.48%	24.22%	-39.03%
Cost of Revenue	43.72	45.88	36.7	39.3	48.42	16.35
Gross Profit	36.9	6.86	16.7	26.2	-0.79	22
Selling, General & Admin	12.62	11.68	12.19	14.96	11.71	12.73
Research & Development	0.99	0.68	0.59	0.78	0.52	29.73
Operating Expenses	13.61	12.36	12.78	15.74	12.23	42.46
Operating Income	23.29	-5.5	3.92	10.46	-13.01	-20.46
Interest Expense	-1.23	-1.19	-1.06	-3.18	-2.53	-7.52
Interest & Investment Income	1.4	1.08	1.3	1.29	1.15	0.4
EBT Excluding Unusual Items	23.46	-5.61	4.15	8.57	-14.4	-27.58
Pretax Income	23.46	-5.61	4.15	8.57	-14.4	-27.58
Income Tax Expense	4.52	1	1.22	0.25	0.53	-
Earnings From Continuing Operations	18.95	-6.6	2.93	8.31	-14.93	-27.58
Net Income	18.95	-6.6	2.93	8.31	-14.93	-27.58
Net Income to Common	18.95	-6.6	2.93	8.31	-14.93	-27.58
Net Income Growth	201.91%	-	-64.73%	-	-	-
Shares Outstanding (Basic)	80	79	73	68	48	44
Shares Outstanding (Diluted)	81	79	81	82	48	44
Shares Change	-2.61%	-3.10%	-1.66%	70.04%	9.81%	51.43%
EPS (Basic)	0.24	-0.08	0.04	0.12	-0.31	-0.62
EPS (Diluted)	0.24	-0.08	0.04	0.09	-0.31	-0.62
EPS Growth	205.32%	-	-57.71%	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	7.67	-13.63	7.39	-2.47	-25.63	-11.74
Free Cash Flow Per Share	0.10	-0.17	0.09	-0.03	-0.53	-0.27
Gross Margin	45.77%	13.01%	31.27%	40.00%	-1.65%	57.37%
Operating Margin	28.89%	-10.43%	7.33%	15.97%	-27.32%	-53.36%
Profit Margin	23.50%	-12.52%	5.49%	12.69%	-31.33%	-71.92%
Free Cash Flow Margin	9.51%	-25.84%	13.84%	-3.77%	-53.80%	-30.62%
EBITDA	24.86	-4.04	5.22	11.65	-11.93	-19.34
EBITDA Margin	30.84%	-7.65%	9.78%	17.79%	-25.04%	-50.44%
D&A For EBITDA	1.57	1.47	1.3	1.19	1.09	1.12
EBIT	23.29	-5.5	3.92	10.46	-13.01	-20.46
EBIT Margin	28.89%	-10.43%	7.33%	15.97%	-27.32%	-53.36%
Effective Tax Rate	19.26%	-	29.42%	2.96%	-	-
Revenue as Reported	80.62	52.74	53.4	65.49	47.64	38.35

SEC Filings: 10-K · 10-Q